検索
Recursion Pharmaceuticals Inc
RXRXウォッチリストに追加
3.200USD
+0.040+1.27%
終値 09-11 16:00（ET）
1.70B時価総額
損失額直近12ヶ月PER
時間外取引 18:44 (ET)3.200USD+0.010+0.31%
時間外取引 18:44 (ET)詳細情報 Recursion Pharmaceuticals Inc 企業名
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.
Recursion Pharmaceuticals Inc プロフィール
企業コードRXRX
会社名Recursion Pharmaceuticals Inc
上場日Apr 16, 2021
最高経営責任者「CEO」Khan (Najat)
従業員数840
証券種類Ordinary Share
決算期末Apr 16
本社所在地41S Rio Grande Street
都市SALT LAKE CITY
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号84101
電話番号13852690203
ウェブサイトhttps://www.recursion.com/
企業コードRXRX
上場日Apr 16, 2021
最高経営責任者「CEO」Khan (Najat)
Recursion Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.11%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
266.64K
-9.38%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
240.76K
+2.12%
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
162.16K
+54.53%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
Dr. Najat Khan, Ph.D.
Dr. Najat Khan, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
72.23K
-111.45%
Dr. Christopher Gibson, Ph.D.
Dr. Christopher Gibson, Ph.D.
Chairman of the Board
Chairman of the Board
17.94K
--
Mr. Zachary Bogue, J.D.
Mr. Zachary Bogue, J.D.
Independent Director
Independent Director
9.38K
--
Dr. Blake Borgeson, Ph.D.
Dr. Blake Borgeson, Ph.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.11%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
266.64K
-9.38%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
240.76K
+2.12%
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
162.16K
+54.53%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
よくある質問
Recursion Pharmaceuticals Incの上位5名の株主は誰ですか？
Recursion Pharmaceuticals Incの上位5名の株主は以下のとおりです。Dr. Dean Y. Li, M.D., Ph.D.
Recursion Pharmaceuticals Inc（RXRX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Recursion Pharmaceuticals Incの株式を保有している機関は721社あり、保有株式の総市場価値は約388.34Mで、全体の74.06%を占めています。2025Q4と比較して、機関の持ち株は46554673.00増加しています。